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Background: The vaginal microbial community plays a vital role in maintaining women’s health. Understanding the
precise bacterial composition is challenging because of the diverse and difficult-to-culture nature of many bacterial
constituents, necessitating culture-independent methodology. During a natural menstrual cycle, physiological
changes could have an impact on bacterial growth, colonization, and community structure. The objective of this
study was to assess the stability of the vaginal microbiome of healthy Canadian women throughout a menstrual
cycle by using cpn60-based microbiota analysis. Vaginal swabs from 27 naturally cycling reproductive-age women
were collected weekly through a single menstrual cycle. Polymerase chain reaction (PCR) was performed to amplify
the universal target region of the cpn60 gene and generate amplicons representative of the microbial community.
Amplicons were pyrosequenced, assembled into operational taxonomic units, and analyzed. Samples were also
assayed for total 16S rRNA gene content and Gardnerella vaginalis by quantitative PCR and screened for the
presence of Mollicutes by using family and genus-specific PCR.
Results: Overall, the vaginal microbiome of most women remained relatively stable throughout the menstrual
cycle, with little variation in diversity and only modest fluctuations in species richness. Microbiomes between
women were more different than were those collected consecutively from individual women. Clustering of
microbial profiles revealed the expected groupings dominated by Lactobacillus crispatus, Lactobacillus iners,
and Lactobacillus jensenii. Interestingly, two additional clusters were dominated by either Bifidobacterium breve
or a heterogeneous mixture of nonlactobacilli. Direct G. vaginalis quantification correlated strongly with its
pyrosequencing-read abundance, and Mollicutes, including Mycoplasma hominis, Ureaplasma parvum, and Ureaplasma
urealyticum, were detected in most samples.
Conclusions: Our cpn60-based investigation of the vaginal microbiome demonstrated that in healthy women
most vaginal microbiomes remained stable through their menstrual cycle. Of interest in these findings was the
presence of Bifidobacteriales beyond just Gardnerella species. Bifidobacteriales are frequently underrepresented
in 16S rRNA gene-based studies, and their detection by cpn60-based investigation suggests that their significance in the
vaginal community may be underappreciated.
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It has long been recognized that the microbial community
of the lower genital tract plays a vital role in maintaining
the reproductive health of women [1]. The vaginal micro-
biota of reproductive-aged women has traditionally been
characterized by culture-based techniques as dominated by
Lactobacillus species, which, among other roles, produce
lactic acid, biosurfactants, hydrogen peroxide, and other
factors that create an inhospitable environment for patho-
genic bacteria [2-7]. Detailed community profiling with
culture-independent techniques has demonstrated that
“healthy” microbial communities are usually dominated by
Lactobacillus crispatus, Lactobacillus iners, Lactobacillus
gasseri, Lactobacillus jensenii, or a combination of these
species, and in a small portion of women, “mixed” profiles
are depleted of lactobacilli and consist of bacteria such as
Gardnerella, Prevotella, Atopobium, Megasphaera, and
Streptococcus [8-14]. The latter has challenged our trad-
itional understanding of the “healthy vaginal microbiome,”
and raises questions about the structure and function of
this community and the host response to it.
The relative compositional stability of the vaginal
microbiome is quite remarkable, given the variability in
the host ecosystem associated with the menstrual cycle,
sexual contact, and introduction of bacteria from the skin
and external environment. In particular, the menstrual cycle
creates an ever-changing vaginal environment, with ovula-
tion, menses, and corresponding fluctuations of estrogen
and progesterone levels affecting bacterial attachment to
the vaginal epithelium [15], cervical mucus production [16],
pH and redox potential [17], and glycogen levels [18].
Culture-based studies in which the microbial community is
characterized at several time points over the cycle have re-
ported a range of findings, from no change in community
composition, to some variation in the aerobic versus anaer-
obic communities over a menstrual cycle, and a greater
proportion of non-Lactobacillus species present during
menses [19-23]. This interindividual variability is mirrored
in culture-independent studies, with some women main-
taining a consistent microbial community throughout mul-
ticycle sampling, others having fluctuations timed with
menses, and some having random fluctuations with no
apparent cause [13,24,25]. Interestingly, in at least some
cases, the overall functional characteristics of the commu-
nity are predicted to be maintained, despite the fluctuations
in the bacterial composition, because the shifts in rela-
tive dominance may be limited to different lactic acid-
producing bacterial species [13].
Our understanding of the vaginal microbiota to date
had been predominantly shaped by culture-based or 16S
rRNA gene culture-independent studies. Although both
approaches contribute a wealth of information on the
microbiota composition, they have limitations. The move
to culture-independent studies was spurred by the labor-intensive methodologies associated with bacteriologic
culture (impractical for large studies), and limited ability
to grow the diverse array of organisms present, as well
as substantial difficulty in accurate determination of
relative abundance. 16S rRNA gene-based methods have
overcome some of the limits of culture, but are known
to have amplification biases and offer limited resolution
for some taxa [26]. Alternative molecular targets, like
the universal cpn60 gene [27], have been used to gain a
different perspective of microbial communities in a
culture-independent fashion.
Similar to 16S rRNA gene-based studies, cpn60 sur-
veys of the vaginal microbiome reveal many largely
lactobacilli-dominated profiles, and better taxonomic
resolution of some nonlactobacilli groups like Gardnerella
and Prevotella [28-31]. For future studies of the vaginal
microbiome, it is very important to understand whether
timing of sampling during the menstrual cycle would
result in significant variability that must be accounted
for in cross-sectional studies of the vaginal micro-
biome in populations.
The primary objective of this study was to characterize
the vaginal microbiome over a natural menstrual cycle
among a cohort of healthy, asymptomatic, Canadian
women, by using the cpn60 gene target. Secondarily, we
aimed to probe for Mollicutes and Bifidobacteria not well
detected by other high-throughput sequencing methods,
and to better understand the temporal stability and/or
variation of the vaginal microbiome within individual
women.Methods
Participants and study design
This longitudinal study was designed to collect
vaginal-swab samples from a cohort of healthy women
weekly over a single menstrual cycle. Women were eli-
gible to participate if they demonstrated comprehen-
sion of the English language to a level necessary to
provide informed consent, were at least 18 years of
age, and had regular menstrual cycles. Individuals were
excluded if they were pregnant or planning to become
pregnant during the study period, had a chronic auto-
immune or inflammatory condition, had an intrauter-
ine device in situ, used hormonal contraceptives, or
were currently taking or had taken antimicrobial medi-
cations (for example, antibiotic or antifungal therapy)
within 4 weeks of enrollment. This study received
ethics approval from the Institutional Review Board at
the University of British Columbia (certificate no. H09-
00860). The sample size was based on previous longi-
tudinal studies of the vaginal microbiome in which a
range of seven to 49 subjects provided sufficient num-
bers for microbiome investigation [13,25,32-34].
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Healthy reproductive-aged women were recruited from
two cohorts of participants in Phase-III clinical trials of
HPV vaccines, a private Obstetrics and Gynecology prac-
tice, and through online and print advertisements placed
in Vancouver, British Columbia, Canada. After obtaining
informed consent, basic demographic and clinical data
were collected by history and from clinical records.
While conducting routine speculum examination (usu-
ally for pap smear screening), clinicians used a Dacron
swab (Copan Diagnostics Inc., Murrieta, CA, USA) to
sample the posterior fornix and lateral vaginal wall. This
sample represented the first of the four samples col-
lected through the menstrual cycle from charts. All par-
ticipants were provided with diaries to log activities
including sexual activity and any interval symptoms.
They were also provided with self-collection kits that
contained sterile flocked swabs designed with a break
point on the handle (Puritan Medical Products Company
LLC, Guilford, ME, USA), collection tubes containing
200 μl of DNAzol-Direct reagent (MRCGENE, Cincinnati,
OH, USA) and detailed collection instructions. After hand
washing, women were instructed to insert the swab
into their vaginas to the half-way point on the handle,
rotate the swab 3 times, remove the swab and place it
into the provided collection tube, break off the handle,
leaving the swab head in the reagent tube, and close
and date the tube.
Samples were stored at ambient temperatures until all
three self-collected samples were acquired at 1-week inter-
vals. This self-sampling method was duplicative of previous
study methods used by ourselves and colleagues in which
we validated the high quality of self-sampling compared
with clinician sampling [35,36].
At the end of the collection period, participants
returned samples and met with study staff to review
their diaries and complete a final interview, in return
for a modest honorarium ($20 CAD). All samples were
de-identified, and by using information from partici-
pants assigned to a menstrual phase by using a
calendar-based method: menstrual, day 1 (onset of
menstruation) to cessation of bleeding (day 4 to 7); fol-
licular, cessation of bleeding to day 12; periovulatory,
day 13 to day 16; luteal, day 17 to days 26 to 32 (com-
mencement of bleeding). If two samples were collected
within the luteal phase, they were numbered sequen-
tially as luteal-I and luteal-II. DNAzol-containing
nucleic acid was separated from the swab head by
centrifugation in the laboratory and used directly as
template for PCR reactions.
Quantitative PCR (qPCR) and conventional PCR
Samples were evaluated for nucleic acid integrity by quanti-
fication of the human cytochrome C oxidase subunit 1(cox1) gene and bacterial 16S rRNA gene (V3 region)
with SYBR Green assays, as described previously [37].
Gardnerella vaginalis was quantified with primers [38]
and SYBR Green assay conditions [39] determined
previously. The presence of Mollicutes (Mycoplasma
or Ureaplasma) was determined by targeting the 16S
rRNA gene by using a conventional, semi-nested PCR
[40], and Ureaplasma spp. were detected by specific
PCR for the multiple-banded antigen gene [41].cpn60 Universal Target (UT) PCR and pyrosequencing
PCR was carried out by using a cocktail of cpn60 UT-
specific primers consisting of a 1:3 molar ratio of
primers H279/H280:H1612/H1613, as described previ-
ously [29,42,43]. Primer sets were modified at the 5' end
with one of 24 unique decamer multiplexing identifica-
tion (MID) sequences, as per the manufacturer’s recom-
mendations (Roche, Brandford, CT, USA). In addition,
the Mollicutes-specific 16S rRNA gene PCR product
from 12 samples was pooled and pyrosequenced. Ampli-
cons were pooled in equimolar concentrations to create
libraries for sequencing on the GS FLX Titanium plat-
form. Emulsion PCR and sequencing were performed at
the National Research Council, Saskatoon, SK, Canada.Analysis of operational taxonomic units (OTUs)
Pyrosequencing data were processed by using the default
on-rig procedures from 454/Roche. MID-partitioned se-
quences were processed with the microbial Profiling
Using Metagenomic Assembly (mPUMA) pipeline (http://
mpuma.sourceforge.net [44]) with default settings to
generate operational taxonomic units (OTUs) with gsAs-
sembler (Roche). OTUs were screened and filtered for chi-
meras with Chaban Chimera Checker (C3), followed by
manual curation. OTU abundance was calculated based
on mapping of sequence reads to OTU sequences by
using Bowtie 2 in mPUMA. OTUs were identified by
watered-Blast comparison [29] to the cpn60 reference
database, cpnDB_nr (downloaded on March 21, 2013,
from www.cpndb.ca, [45]), and OTUs having the same
best database reference were grouped together into near-
est neighbor “species,” whereas OTUs having less than
55% identity to any reference sequence were removed
from the dataset as non-cpn60 sequence. Raw sequence
data files were deposited to the NCBI Short Read Archive
(BioProject PRJNA210319). Samples with fewer than 100
sequence reads after processing were removed, leaving a
total of 76 samples from 27 women for analysis.Statistical methods
We examined the demographic and clinical parameters
of the study cohort by using descriptive statistics.
Chaban et al. Microbiome 2014, 2:23 Page 4 of 12
http://www.microbiomejournal.com/content/2/1/23Alpha and beta diversity comparisons
Quantitative Insights Into Microbial Ecology (QIIME)
pipeline [46] was used to calculate Shannon diversity
index, Chao1 estimated number of species, and jack-
knifed beta diversity from Bray-Curtis distance matrices.
For these analyses, the data grouped to the nearest
neighbor “species” level were used, and all diversity mea-
sures were bootstrapped 100 times at 1,000 reads per
sample or their sample maximum when less than 1,000.
Rarefaction plots of Chao1 were generated to ensure
that an adequate sampling depth for each sample was
achieved.
Alpha diversity measures of the samples were averaged
across the 100 bootstrapped datasets at 1,000 reads per
sample, and compared among the four menstrual phases
(menstrual, follicular, periovulatory, and luteal) by using
a linear nested mixed-effects model for Shannon diver-
sity and a Poisson nested mixed-effects model for Chao1
nested within subject. Post hoc Tukey comparisons were
conducted when needed by using the “multcomp” pack-
age in R [47,48].
Beta diversity (ecologic distance) was calculated as the
average pair-wise distances from the 100 bootstrapped
datasets at 1,000 reads per sample. We compared eco-
logic distances of samples within subjects with those
between by comparing all within-subject pair-wise dis-
tances with all between-subject pair-wise distances by
using ANOVA. In addition, we compared all pair-wise
distances within menstrual phases pooled (that is, all
within menstrual, and all within follicular, all within
periovulatory, and all within luteal) with all between-
phase distances (again pooled) by using ANOVA. These
analyses do not take into account multiple samples
per subject, as they are based on pair-wise distances
among samples; they should therefore be considered
exploratory.
Hierarchic clustering
As the average of the bootstrapped distance matrices did
not include the samples with <1,000 reads, we generated
another Bray-Curtis distance matrix on the proportion
of reads of each nearest neighbor “species” per sample
by using only taxa that represented at least 1% of the
reads of at least one sample by using the vegan package
in R [49]. Hierarchic clustering was achieved by using
this distance matrix and ward linkage. Bootstrap support
for clusters was assessed by using average Jaccard simi-
larities from the clusterboot function in the “fpc” pack-
age in R [50].
The results of the clustering are nearly identical when
the bootstrapped averages for all samples with >1,000
reads are used instead. The additional samples contrib-
ute to some clusters, but do not change the structure of
the clustering results.Community stability
In addition to the linear mixed-effects models on alpha
diversity, and the comparisons of within versus between-
woman ecologic distances, we used a graphic method to
assess the “stability” of microbial communities across
samples from the same subject. To explore how the rela-
tive abundance of taxa changed over time, we plotted
proportional area plots of taxonomic composition for
each woman by using taxa that represented at least 10%
of at least one sample. Women with samples that
had <25% change in the proportions of dominant taxa
were considered stable. Stability by this measure, and
stability as a measure of whether a woman remained in
one of the previously defined clusters, or switched among
clusters, were tested for associations with BMI (under-
weight, normal, overweight, obese), previous pregnancy,
marital status (partnered versus single), alcohol use, vaginal
sex, use of condoms, and use of unscented tampons during
the study period by using Fisher Exact tests.
Correlation of sequencing-read abundance to qPCR for
Gardnerella vaginalis
The proportion of total pyrosequencing reads obtained
per sample corresponding to G. vaginalis (nearest neigh-
bor “species”) were compared with the absolute amount
of G. vaginalis DNA detected by qPCR in each sample
by using a Spearman rank-order correlation test (SPSS
Inc., Chicago, IL, USA).
Results
Study cohort
Demographic and clinical characteristics of the 27 study
participants are summarized in Table 1. All women had
no signs or symptoms of a vaginal infection at the time
of enrollment. All reported having normal menstrual cy-
cles of approximately 28 days (range, 26 to 31 days).
Most women (81.5%) reported clinical diagnosis of a va-
ginal infection (for example, yeast vaginitis, bacterial
vaginosis (BV)) or a sexually transmitted infection (STI)
at some time in their life. Only two women (7.4%) re-
ported a diagnosis of BV in their lifetime, and only one
woman (3.7%) reported having a BV episode within the
past year. None of the women reported use of douche
products during the study period.
Sample integrity evaluation
To confirm the presence of amplifiable nucleic acid in
the DNAzol samples, samples were assayed for human
cytochrome C oxidase gene and total bacterial 16S rRNA
gene content. Human DNA was detectable in 72 (98.6%)
of 73 samples tested, whereas total 16S rRNA gene con-
tent fell within the ranges of less than 104 copies/swab
(33 samples), 104 to 105 copies/swab (31 samples) or 105
Table 1 Demographic and clinical data for study
participants (N = 27)
Demographics
Age 34.96 ± 4.17 (18-53)
BMI 23.47 ± 1.86 (16.8-36)
Ethnicity
Asian 9 (33.3%)
Caucasian 15 (55.6%)
Other 3 (11.1%)
Substance use
Current smoking 2 (7.4%)
Current alcohol use 20 (74.1%)
Sexual history
Marital status
Partnered 9 (33.3%)
Single 18 (66.7%)
Sexual partners in past year 1.04 ± 0.28 (0-3)
Sexual partners in past 2 months 0.78 ± 0.23 (0-2)
Vaginal intercourse during study period 17 (63.0%)
Condom use during study period 8 (29.6%)
Previous pregnancy 10 (37.0%)
Surgical sterilization 4 (14.8%)
Menstrual cycle
Cycle duration (days) 28.05 ± 0.68 (26-31)
Tampon use during study period 12 (44.4%)
BV and STI history
Diagnosed with BV, yeast, or STI in lifetime 22 (81.5%)
Diagnosed with BV in lifetime 2 (7.4%)
BV episode in past year 1 (3.7%)
Antimicrobial use in past 2 months a
Oral 1 (3.7%)
Topical 2 (7.4%)
aNo intravaginal antibiotics.
BMI, body mass index; BV, bacterial vaginosis;
STI, sexually transmitted infection.
Continuous variables are reported as means ± 95% CI (range).
Categoric variables are reported as N (%).
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cpn60-UT amplicons for pyrosequencing.Microbiome profile generation
After sample collection and processing, an average of
three vaginal samples per woman (range, 1 to 4; median,
3) were available for analysis. Microbial profiles were
determined from an average of 7,585 sequence reads per
sample (range from 125 to 37,419; median, 4,256),
generating 567 unique OTUs. When combined at thenearest neighbor “species” level (OTU with same best
reference database match), 73 bacterial “species” were
identified with an average minimum percentage identity
of 94.0% ± 7.1%, an average maximum percentage iden-
tity of 96.6% ± 5.2%, and an average overall percentage
identify of 95.5% ± 5.5% to the reference sequence. A
detailed summary of the nearest neighbor “species”
identified in each sample is provided in an additional file
(see Additional file 1).
To evaluate whether the number of sequence reads
per sample was a sufficient representation of the vagi-
nal microbiota, rarefaction plots of Chao1-estimated
number of species were calculated. Graphic depictions
of the rarefaction plots for subsampled data are pre-
sented in an additional file (see Additional file 2). In
most samples, the Chao1 values remained relatively
consistent throughout (flat line across the plot), indicating
that the sample richness did not change significantly when
100 to 1,000 sequence reads per sample were examined.
This consistency indicated that most of the community was
captured at the sampling depth achieved.Vaginal microbiome richness, diversity, and ecologic
distance
The Shannon diversity index provides a quantitative
measure of species diversity (richness and evenness),
whereas the Chao1-estimated number of species provides
a quantitative measure of species richness. No significant
difference was found among the menstrual phases (linear
mixed-effect model; likelihood ratio test, P = 1) in the
average Shannon diversity of vaginal microbiome samples
after accounting for multiple samples from each indivi-
dual. However, a significant relationship between men-
strual phase and the Chao1 estimated number of species
was observed (Poisson mixed-effects model: likelihood
ratio test, P = 0.03), with post hoc comparisons suggesting
that the follicular phase had, on average, 1.3 more species
than the luteal phase (adjusted P = 0.01), after multiple
samples per individual were taken into account. None of
the other menstrual-phase comparisons showed signifi-
cant differences. Figures showing the average Shannon
diversity index and Chao1 estimated number of species
calculated for each menstrual phase are presented in an
additional file (see Additional file 3).
Comparisons of communities between vaginal micro-
biome profiles showed on average greater ecologic dis-
tance between samples from different women (median =
0.97; range = 0 to 1) than among samples from the same
woman (median = 0.29; range = 0 to 0.98; Figure 1:
ANOVA, F1, 2,209 = 133.4; P < 0.0001). No discernible
difference in ecologic distance was noted when comparing
samples between menstrual phases versus within menstrual
phases.
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Figure 1 Average Bray-Curtis ecologic distance from jackknifed
distance matrices of vaginal microbiomes. The horizontal lines
indicate the median distances; boxes indicate the interquartile
ranges; whiskers extend to 1.5 times the interquartile range; and the
diamonds indicate means.
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Hierarchic clustering of all 76 samples revealed five clus-
ters with average Jaccard similarities from 100 resam-
pling runs of 0.99, 0.85, 0.96, 0.80, 0.78 (left to right in
Figure 2). Clusters 1, 2, 3, and 5 from left to right in
Figure 2) were dominated by L. crispatus (29 samples from
13 women), L. jensenii (12 samples from five women),
Bifidobacterium breve (a non-Gardnerella Bifidobacteriales:
seven samples from two women), and L. iners (20 samples
from 11 women). The remaining cluster contains a hetero-
geneous mixture of dominant taxa including Alloscardovia
omnicolens, Bifidobacterium longum, Streptococcus agalac-
tiae, G. vaginalis subgroup A, and mixed Actinobacteria
species (eight samples from five women).
Of the 26 women who had multiple samples in the
analysis, 18 had all their vaginal profiles belonging to the
same cluster, whereas eight had different cluster affilia-
tions over the menstrual cycle. Four of the women who
had cluster switches (W14, W27, W30, and W33) transi-
tioned between the L. iners cluster and the L. crispatus
cluster and so remained Lactobacillus dominated overall.
One woman (W29) transitioned between the L. crispatus
and the L. jensenii cluster, and one woman (W23) transi-
tioned between all three Lactobacillus-dominated clus-
ters. None of the women transitioned into or out of the
B. breve-dominated cluster, whereas two women (W12
and W25) transitioned from the heterogeneous cluster
to a Lactobacillus-dominated cluster over the menstrual
cycle (Figure 3).
A relation did not appear to be present between clus-
tering and menstrual phase, as most clusters containedsamples from all phases (Figure 2). An inventory of the
dominant species profile identified from the different
menstrual-phase samples provided by each individual is
provided in a supplementary file (see Additional file 4).
To gain a clearer picture of the stability of vaginal
microbiome community composition over time, propor-
tional area plots of the taxonomic composition of each
woman’s microbiome were assembled (Figure 3). The
plots grouped into four general types of vaginal micro-
biome profiles. The first group consisted of 12 women
with relatively stable bacterial profiles over the sampling
course (<25% variability in relative proportion of domin-
ant bacterial species; Figure 3A). These women were also
among those who did not switch between community
clusters, as defined earlier by hierarchic clustering.
The second group comprised nine women with micro-
biota profiles that consisted of the same bacterial or-
ganisms, but the relative proportions of each “species”
fluctuated by >25% over time (Figure 3B). Five of these
subjects also switched between clusters, as defined
earlier, whereas the remaining four did not.
The third group consisted of three women who
showed dramatic changes in their microbiota over the
sampling course (a complete change in the dominant
members of the community; Figure 3C), whereas the
fourth group contained two women with >25% variabil-
ity in relative proportions of bacterial “species,” as well
as an apparent introduction of new bacterial “species”
(Figure 3D).
Differences in microbiome composition were reflected
in analogous differences in the Shannon diversity index
and Chao1-estimate values. Plots depicting temporal
variation in the bootstrapped Shannon diversity index
and Chao1 estimates for each individual are included in
an additional file (see Additional file 5).
No evidence was seen that “stability,” as defined
either as <25% change in dominant taxa, or as cluster-
switching, was related to BMI category, previous preg-
nancy, marital status, alcohol use, vaginal sex, use of
condoms, or use of unscented tampons during the
study period by Fisher Exact tests (all P > 0.05). Other
clinical covariates were not investigated, as too few
subjects existed per category (Table 1).
Evaluation of nearest-neighbor “species” abundance by G.
vaginalis levels
In an effort to confirm independently whether the nearest-
neighbor “species” sequence read abundance reflected ac-
tual bacterial species levels in the samples, G. vaginalis was
quantified in the samples, and the quantitative PCR results
compared with sequence read counts. G. vaginalis was
chosen as a target because it was detected in 74% of sam-
ples at a wide range of sequence read abundances. The pro-
portion of total reads obtained per sample corresponding
periovulatory
menstrual
follicular
luteal
Menstrual Phase
Clusters: 1 2 3 4 5
Actinomyces neuii
Alloscardovia omnicolens
Atopobium parvulum
Atopobium vaginae
Bifidobacterium bifidum
Bifidobacterium breve
Bifidobacterium dentium
Bifidobacterium longum
Brachybacterium faecium
Brevibacterium mcbrellneri
Brevibacterium sp.
Corynebacterium accolens
Corynebacterium glucuronolyticum
Corynebacterium jeikeium
Corynebacterium lipophiloflavum
Corynebacterium xerosis
Gardnerella vaginalis Group A
Gardnerella vaginalis Group B
Gardnerella vaginalis Group C
Mobiluncus curtsii
Propionibacterium sp.
Bacteroides coagulans
Porphyromonas uenonis
Prevotella buccalis
Dialister micraerophilus
Lactobacillus crispatus
Prevotella disiens
Prevotella timonensis
Lactobacillus gasseri
Lactobacillus iners
Lactobacillus jensenii
Lactobacillus sp.
Megasphaera sp.
Streptococcus agalactiae
Streptococcus parasanguinis
Streptococcus salivarius
Acidovorax sp.
Oligella urethralis
Mollicutes
Ureaplasma
Percent of profile
Figure 2 Hierarchic clustering of vaginal microbiome profiles by nearest-neighbor “species.” Only nearest-neighbor “species” comprising
at least 1% of at least one sample are included. The color scale reflects the proportion of the total profile each “species” represented. Samples
were divided into five clusters (indicated by numbers) based on average Jaccard similarities from 100 resampling runs. Colored blocks on the
top indicate the menstrual phase of each sample. Mollicutes- and Ureaplasma-positive samples are indicated by black boxes below the heatmap
(gray boxes indicate that the sample was not tested).
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of G. vaginalis detected by qPCR in each sample (rs = 0.405;
n = 76; P < 0.001).
Mycoplasma and Ureaplasma in the vaginal microbiome
A known limitation of cpn60-based microbial profiling
is that some species of Mollicutes do not contain this
gene. To address this issue, all samples were screened
for Mollicutes by using a conventional PCR-based test
designed to detect Mycoplasma and/or Ureaplasma
species. Mollicutes were detected in 59 (80.8%) of 73
samples, representing 23 (85.2%) of 27 women (Figure 2).
When a Ureaplasma-specific PCR was applied to the same
samples, 23 (31.5%) of 73 returned positive results from 10
(37.0%) of 27 women, comprising of 18 samples (24.7%)
with U. parvum (eight women) and five samples (6.8%)
with U. urealyticum (two women). To understand the com-
position of the Mollicutes-level PCR products further, PCR
products from 12 samples (representing five women in ei-
ther follicular, periovulatory, or luteal phases) were pooled
and pyrosequenced to generate 54,926 reads. Mollicutes-
like sequences accounted for 77.7% of reads, with clearidentities (>95%) to Mycoplasma hominis and Ureaplasma
spp. observed for 76.2% of the sequences (Ureaplasma can-
not be speciated with this region of the 16S rRNA gene).
The remaining 1.5% of Mollicutes-like reads grouped into
seven distinct OTU that had only 85% to 90% identity to
known species, suggesting that novel Mollicutes may be
present in the microbiome.
Sequences matching Mycoplasma genitalium were not
detected. Interestingly, this PCR also generated ampli-
cons from several Staphylococcus species, including S.
epidermidis (17.3% of reads), S. pasteuri (0.21% of reads),
S. hyicus (0.04% of reads), and Staphylococcus spp. (2.9%
of reads), as well as the Lactobacillus species L. iners
(1.6% of reads), L. crispatus (0.04% of reads), and L. jensenii
(0.07% of reads). This indicated that some of the PCR
product generated was not Mollicutes-derived and
suggests that this PCR assay has the potential to
generate a false-positive result.
Discussion
The results of our cpn60-based study of the vaginal
microbiota through a menstrual cycle demonstrate that
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Figure 3 Vaginal microbiome profiles over the menstrual phase. Data are presented as proportion of the total sequence reads obtained for
each sample, with the height of the ordinate corresponding to 100%. Sampling times are indicated with vertical broken lines, and menstrual-cycle phase
for each sample is indicated on the abscissa (M, menstrual; F, follicular; P, periovulatory, L-I, luteal I; L-II, luteal II, as defined in the text). Profiles are arranged
to reflect women with relatively stable microbiomes (<25% change) (A), profiles consisting of the same organisms, but the proportions of these organisms
fluctuated by >25% over time (B), profiles that had dramatic changes over the sampling time (C), and profiles with a mixture of changing
proportions and introduction of new organisms (D). Sample identification numbers appear in the upper left corner for each individual. The
legend includes nearest-neighbor "species" that account for at least 10% of the sequence reads in at least one sample.
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healthy women, with L. crispatus, L. iners, and L. jensenii
being the dominant members. This is consistent with
previously reported studies [12,13,25]. Of note, Lactoba-
cillus gasseri is prominent in other studies [12,13], but it
was not a dominant organism in any woman’s micro-
biota profile in this study.
In overall richness, diversity, and ecologic distance, we
observed an element of a personalized compositional
pattern in most women over time: profiles generated
from samples collected at different menstrual phases
from the same woman showed a higher degree of shared
similarity in community structure versus profiles gener-
ated from different women but collected in the same
menstrual phase [13,51]. However, given the limited
sample size, the extent of a “personalized” microbiota
remains to be confirmed.
We did observe a statistically significant relation be-
tween menstrual phase and the Chao1 estimated num-
ber of species, in which follicular-phase samples had on
average 1.3 more species than did luteal-phase samples.
However, we do not believe that this observation is bio-
logically significant, given that presence or absence of a
single species can be affected by technical nuances and
random sampling effects [52].
Genital Mycoplasma and Ureaplasma have been asso-
ciated with female genital infections such as vaginitis,
cervicitis, and pelvic inflammatory disease, and with a
variety of other negative reproductive and neonatal out-
comes [53-55]. M. hominis, M. genitalium, U. parvum,
and U. urealyticum are regularly detected in vaginal
samples by using culture or taxon-specific PCR methods,
although the reported prevalence is wide-ranging (20%
to 80% depending on the study population). These spe-
cies are much more rarely reported in 16S rRNA gene-
based microbiota analysis [12,14,51], likely because of
universal primer bias [56]. The lack of a cpn60 gene in
Mollicutes is not a universal phenomenon, because sev-
eral species of Mycoplasma, including M. genitalium do
have a cpn60 gene. However, M. genitalium has not been
detected in any cpn60-based studies of the human
vaginal microbiome to date [28-30]. Mycoplasma and
Ureaplasma are commonly reported vaginal constituents
[57,58], further supporting the suggestion that these or-
ganisms are part of the vaginal microbiota of manyclinically healthy women. As well, deep sequencing re-
vealed seven novel Mollicutes-like sequences that could
indicate uncharacterized species. Interestingly, deep pyrose-
quencing of the reportedly Mollicutes-specific PCR prod-
ucts from a pool of 12 PCR-positive samples showed that
primer specificity was imperfect. The generation of
amplicon from other organisms, particularly Staphylo-
coccus and Lactobacillus species, that was the same
size as the targeted Mollicutes product might result in
some overreporting of Mollicutes detection in studies
using these primers.
Our study diverges from several others in the number
of vaginal profiles dominated by non-Gardnerella Bifido-
bacteriales. Bifidobacterium species (high G + C, Gram
positive, Actinobacteria) are known members of the va-
ginal microbiota, and genera like Bifidobacterium and
Alloscardovia have been isolated from vaginal samples
in several culture-based investigations [19,21,59-62].
Culture-independent studies based on the 16S rRNA
gene have also reported Bifidobacterium species in the
vaginal microbiome [14,63,64], with one study finding
it the dominant community member for two of 20 women
in the study [65]. More commonly, 16S rRNA gene-based
investigations tend not to report Bifidobacterium in the va-
ginal microbiome [12-14,51]. This phenomenon echoes
previous findings in studies of the intestinal microbiome, in
which culture-based investigations revealed a wealth of
Bifidobacterium, whereas 16S rRNA gene-based culture-
independent studies detected very few, leading to the dis-
covery that many universal 16S rRNA gene PCR primers
were a poor match for this genus [26,66,67].
Further hindering the identification of Bifidobacterium
is its relatedness to G. vaginalis, a species that is preva-
lent in the vaginal microbiota, and belongs to the same
taxonomic family [68]. The cpn60-based universal PCR
protocol used in this study has been shown experimen-
tally to represent bifidobacteria more accurately in intes-
tinal microbiomes compared with 16S rRNA gene-based
universal PCR [26], and the cpn60 target sequence is
clearly distinguishable between Gardnerella and Bifidobac-
terium (average sequence identity of only 75%, compared
with 16S rRNA gene identities of >90%). The finding that
five women in our study group had Bifidobacterium
breve, Bifidobacterium longum, or Alloscardovia omnicolens
as a dominant vaginal organism seems reasonable.
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members of the intestinal microbiota [69], although
their role in the vaginal microbiota has not yet been
elucidated. It is conceivable that Bifidobacterium, lac-
tic acid-producing bacteria, could have a protective or
health-promoting effect in the vagina analogous to
Lactobacillus. Bifidobacteria also appear to play an im-
portant role in early infant health and development [70],
and their presence in the vaginal microbiota of healthy,
reproductive-aged women could provide a means of trans-
fer from the mother to the newborn during birth.
Measures were taken to evaluate sample quality, repre-
sentativeness of the sequence read abundance, and
known limitations of the technique used. Sample quality
was assessed from the ability to amplify both human
(via the cox1 gene) and bacterial DNA (via the 16S
rRNA and cpn60 genes) from the samples. The fact that
bacterial amplicon could be generated from all samples
and human amplicon from all but one sample indicated
that nucleic acid quality was maintained at a sufficient
level for analysis. It was then determined empirically that
cpn60 amplicon generation and sequencing faithfully
represented actual starting amounts of target in the ex-
ample case of G. vaginalis. In addition, it was anticipated
that Mollicutes species would be poorly characterized by
cpn60 analysis, so targeted investigation of this important
group was separately undertaken. All of these measures
added additional experimental data to the results generated
from the cpn60 analysis and helped to ensure that the de-
scriptions of the vaginal microbiota under investigation
were as faithful and representative as possible.
The results of this study suggest that the specific men-
strual phase of a woman is not predictive of her vaginal
microbiota at that time. For 18 (69%) women, all the
samples collected throughout the menstrual cycle clus-
tered together by composition. An additional six (23%)
women transitioned between Lactobacillus-dominated
clusters throughout the menstrual cycle, whereas only
two (8%) women had sample compositions transition
from the heterogeneous cluster to a Lactobacillus-domi-
nated cluster. No apparent pattern of vaginal microbiome
composition change was noted by menstrual phase, and no
association with personal health practices or sexual activity.
It is worth noting that the majority of the women in this
study had microbiota dominated by Lactobacillus species.
Although this is a commonly observed trend, we recognize
that the observations made from this cohort may not apply
to populations of women with a higher prevalence of non-
Lactobacillus-dominated vaginal microbiota. Further stud-
ies involving more Canadian women over longer periods
are needed to continue addressing important questions
about the composition and stability of the vaginal
microbiome. It is also important to ensure that these
studies are done in different cohorts with variableethnic and behavioral characteristics in multiple sites
around the world.
Conclusions
The composition of the vaginal microbiome did not ap-
pear to be directly linked to the menstrual phases of
women in our study. Some woman had vaginal microbial
communities that were apparently stable in composition
and abundant throughout the menstrual cycle, whereas
others underwent moderate or dramatic shifts over time.
Despite these shifts, the overall community composition
tended toward one of only a few compositional structure
types dominated by Lactobacillus species at any single
time. The use of the protein-coding cpn60 gene as a
community barcode marker, unlike some other methods,
revealed Bifidobacteriales-dominated vaginal profiles whose
role in health warrants further investigation. The degree to
which specific aberrations of a woman’s vaginal microbiome
occur and lead to symptomatic disease requires urgent
attention, given the prevalence of such illnesses and its ad-
verse effects on quality of life and reproductive outcomes.Additional files
Additional file 1: Detailed summary of nearest-neighbor species
identified in each sample. Summary table of nearest-neighbor “species”
identified in each sample, minimum, maximum, and average percentage
identity of the nearest-neighbor “species” label to database reference
sequences, number of OTU (unique cpn60 sequence) per nearest neighbor
“species,” and actual nearest-neighbor “species” sequence abundance
(pyrosequencing reads obtained) for each sample.
Additional file 2: Rarefaction plots of Chao1-estimated numbers of
species values for all 76 study samples. For each sample, 100 to 1,000
sequence reads (in increments of 25 sequences) were subsampled 100
times from the data, and the average Chao1-estimate numbers of species
were plotted for each increment. If a study sample had been thoroughly
sequenced, the data plotted would approach an asymptotic plateau,
indicating that further sequencing would not yield significantly more
new species. This was done to confirm that the sequencing depth used
in this study was adequate to capture the sample richness.
Additional file 3: Average Shannon Diversity and Chao1-estimated
numbers of species by menstrual phase. Average Shannon Diversity
(A) and Chao1-estimated number of species (B) by menstrual phase.
Phases are defined as menstrual, day 1 (onset of menstruation) to cessation of
bleeding (days 4 to 7); follicular, cessation of bleeding to day 12; periovulatory,
day 13 to day 16; luteal, day 17 to day 26 to 32 (commencement of bleeding).
The error bars indicate 95% confidence intervals. The only statistically
significant difference determined was between the Chao1-estimated
numbers of species between the follicular and luteal phases; however,
we do not believe this to be biologically significant.
Additional file 4: Cluster affiliation for all 76 study samples.
Summary table identifying the hierarchic clustering assignment of all 76
samples into one of five clusters based on Jaccard similarities. These data
are depicted graphically in Figure 2.
Additional file 5: Temporal variation in Bootstrapped Shannon
diversity index and Chao1 estimates for each individual. Graphs
showing the change in bootstrapped Shannon diversity index (A) and
Chao1 estimates (B) for each woman (N = 27) by the day each sample
was taken. The plots reflect the findings that many women had diversity
statistics that remained consistent throughout the study period, whereas
some women had changes in the values of these measures.
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